Costs
Part of Healthcare Advertising Guide for Small Teams
Which Healthcare Advertising Questions Come Up Most
common healthcare advertising questions in 2027 cover authorization, drug promotion, audience data, claims, disclosures, platform approval, records, and corrections.
What to take away
- Classify the advertiser, offer, data, audience, and medium before choosing a rule.
- A platform's approval does not settle federal, state, professional, privacy, or product requirements.
- Keep the evidence and reviewer behind every material claim and disclosure.
Which healthcare advertising questions come up most often?
Common healthcare advertising questions become easier when the team stops treating healthcare as one product class. A clinic service, prescription drug, device, supplement, health plan, research study, and public campaign can have different owners and obligations.
These questions decide the rule set, so they come up first. Each answer changes what the next question can be.
- Who is the advertiser, and who owns the decision? Name the legal entity, sponsor, account, and public identity. The accountable advertiser assigns qualified authority for each decision.
- What exactly is offered? Identify the exact service, product, study, plan, or program. The offer type decides which regulator and platform policy apply.
- Can we use this patient information or audience? Map the data field, source, purpose, recipient, and disclosure. Map authorization or other authority, vendor, retention, and deletion or correction path.
- Which regulator or reviewer has jurisdiction? Check FDA, FTC, state attorneys general, professional boards, and platform policies. The answer decides which rules apply. For example, the Texas attorney general can seek penalties and restitution under the Texas Deceptive Trade Practices Act, and a state medical board can suspend a license over misleading advertising.
- What claims, disclosures, and disclaimers are required? Match approved wording, support, limits, and a named reviewer to each claim. A disclosure cannot fix an unsupported claim.
- What records must stay on file? Keep source pages, review notes, claims, and versions. Keep audience settings, exclusions, dates, and approvals. Set a dated review trigger.
- How do we correct a problem? Track complaints, corrections, and final disposition. Compare records before changing a metric or audience.
Three federal statutes cover most of this ground. HIPAA governs how covered entities use and disclose protected health information. The Federal Food, Drug, and Cosmetic Act governs drug, device, and related labeling and promotion. The FTC Act bans deceptive and unfair advertising. State law and professional rules can add requirements on top of all three.
Can patient information be used for an ad?
HHS answers the narrow question of when patient authorization is required for HIPAA marketing and identifies limited circumstances concerning face-to-face communications and nominal promotional gifts. The answer also addresses remuneration language.
Apply it only after confirming that HIPAA, protected health information, the covered entity, and the marketing definition are relevant to the actual use.
Do not lead with an audience tool. Work from the data map in question 3, because the targeting choice follows from it.
A broad campaign name or existing relationship authorizes no paid placement, lookalike, upload, or follow-up. Clinics that map data fields this way still need a scoped rule map, which the healthcare marketing compliance guide explains step by step.
Who oversees prescription drug promotion?
FDA's page on the Office of Prescription Drug Promotion describes OPDP's role in reviewing prescription drug advertising and promotional labeling for truthful, balanced, and accurate communication. The page concerns promotion made by or for relevant prescription drug sponsors, not every clinic, device, over-the-counter product, or public health message.
| Question | Evidence needed |
|---|---|
| Who is advertising? | Legal entity, sponsor, account, and public identity |
| What is offered? | Exact service, product, study, plan, or program |
| Why this audience? | Documented targeting fields, source, and exclusions |
| What is claimed? | Approved wording, support, limits, and reviewer |
| What happens next? | Working destination, capacity, response, and correction |
| Which regulator has jurisdiction? | Product type, sponsor, medium, state rules, and professional rules |
| What must be disclosed? | Exact wording, placement, format, and reviewer |
| What records stay? | Source, version, approval, date, and disposition |
Does a disclosure solve the problem?
Only when the underlying claim is supportable and the qualification is clear where people need it. A disclosure cannot reverse a false headline, cure an unavailable service, turn an atypical testimonial into a typical result, or make a sensitive audience appropriate. Review the complete impression in every delivered format.
For example, a paid patient post needs wording such as "I was paid by this clinic to share my experience," placed where a viewer sees it without tapping or clicking.
What records should a team keep?
Keep source pages, review notes, claims, versions, and rendered combinations. Keep audience settings, exclusions, dates, spend caps, and placements. Keep approvals, change history, delivery definitions, destination tests, and complaints. Keep corrections and final disposition.
A screenshot should show the relevant state and date without retaining unnecessary personal information.
How do you resolve the question with a decision record?
The GAO evaluation design guide sets out how to link an evaluation question to a design and an evidence plan, and how to state what the findings can and cannot support. Federal evaluation guidance does not make a local marketing result causal or transferable.
Teams can borrow the same evidence discipline from a healthcare content marketing checklist when they document an advertising answer.
The W3C Privacy Principles statement lists shared privacy goals for web systems, including data minimization, and places the duty to protect privacy on designers rather than on users. It sets no advertising rule, so the governing law and the live settings decide the case.
A useful answer identifies the decision owner, eligible population, evidence period, method, and action. It also states what the result cannot establish. Save the definition and date with the answer.
If the same question returns, compare the records before changing the metric. That step exposes a changed population or source instead of treating every difference as new behavior.
For common healthcare advertising questions, keep the evidence record beside the decision so a reviewer can reproduce the reasoning without relying on memory. Set the next review date and name the change that would trigger an earlier check.
Common questions
Is every healthcare ad reviewed by FDA?
No. FDA has defined product and sponsor jurisdiction. Other laws, regulators, professional rules, and platform policies may apply.
Can an agency make the compliance decision?
An agency can provide evidence and specialist work, but the accountable advertiser must assign qualified authority for each decision.
Should an approved ad run forever?
No. Service facts, evidence, policies, and audiences need dated review triggers. Destinations, capacity, and requirements need the same.
Which question comes up first?
Who is the advertiser, and who owns the decision. That answer sets the legal entity, sponsor, account, and public identity.
Does a platform approval settle the question?
No. A platform approval does not settle federal, state, professional, privacy, or product requirements.
Can a disclosure fix a weak claim?
No. A disclosure cannot reverse a false headline, cure an unavailable service, turn an atypical testimonial into a typical result, or make a sensitive audience appropriate.
